Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 1

Abstract

.

Authors and Affiliations

Won Sriwijitalai, Viroj Wiwanitkit

Keywords

Related Articles

Congenital Diaphragmatic Hernia and Iron Defi ciency Anemia

To the Editor, The case described by Dr. Sarper and her colleagues in their letter to the editor, entitled “Severe iron defi ciency anemia due to late presentation of congenital diaphragmatic hernia in a toddler”, was n...

Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming

Objective: Cancer cell reprogramming is a potential tool to study cancer progression, disease pathology, and drug sensitivity. Prior to performing cancer reprogramming studies, it is important to evaluate the stemness pr...

Download PDF file
  • EP ID EP548205
  • DOI 10.4274/tjh.galenos.2018.2018.0397
  • Views 95
  • Downloads 0

How To Cite

Won Sriwijitalai, Viroj Wiwanitkit (2019). Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turkish Journal of Hematology, 36(1), 53-54. https://europub.co.uk/articles/-A-548205